Ticker Scorecard - AQST Basics Company: Aquestive Therapeutics, Inc. IPO Date: July 23, 2018 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $320.95M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 3.75% Avg Daily Range (30 D): $0.12 | 2.91% Avg Daily Range (90 D): $0.14 | 3.07% Institutional Daily Volume Avg Daily Volume: .65M Avg Daily Volume (30 D): 1.4M Avg Daily Volume (90 D): 1.31M Trade Size Avg Trade Size (Sh.): 183 Avg Trade Size (Sh.) (30 D): 158 Avg Trade Size (Sh.) (90 D): 142 Institutional Trades Total Inst.Trades: 106 Avg Inst. Trade: $1.78M Avg Inst. Trade (30 D): $1.42M Avg Inst. Trade (90 D): $1.43M Avg Inst. Trade Volume: .42M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.34M Avg Closing Trade (30 D): $1.48M Avg Closing Trade (90 D): $1.68M Avg Closing Volume: 541.38K     News Jun 27, 2024 @ 12:00 PM Aquestive Therapeutics to Participate in Leerink P... Source: Aquestive Therapeutics, Inc. Jun 3, 2024 @ 12:00 PM Aquestive Therapeutics Announces Executive Appoint... Source: Aquestive Therapeutics, Inc. May 24, 2024 @ 12:59 PM 5 Small Drug Stocks to Buy From a Recovering Indus... Source: Kinjel Shah May 9, 2024 @ 12:00 PM Aquestive Therapeutics to Participate in The Citiz... Source: Aquestive Therapeutics, Inc. May 7, 2024 @ 11:00 PM Compared to Estimates, Aquestive Therapeutics (AQS... Source: Zacks Equity Research Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.13 $-.03 $-.17 Diluted EPS $-.13 $-.03 $-.17 Revenue $ 13.54M $ 20.1M $ 12.05M Gross Profit $ 9.11M $ 15.57M $ 7.66M Net Income / Loss $ -11.51M $ -2.75M $ -12.83M Operating Income / Loss $ -8.29M $ .06M $ -8.96M Cost of Revenue $ 4.44M $ 4.53M $ 4.39M Net Cash Flow $ -11.98M $ -5.33M $ 71.33M PE Ratio